What are the differential diagnoses for a patient presenting with an upper gastrointestinal bleed and leukocytosis?

Differential Diagnosis for Upper GI Bleed with Leukocytosis

In a patient with upper GI bleeding and elevated white blood cell count, consider the common causes of nonvariceal UGIB first—peptic ulcer disease being most likely—while recognizing that leukocytosis typically reflects bleeding severity rather than indicating a specific etiology. 1, 2

Understanding the Clinical Context

Leukocytosis occurs in approximately 63% of patients with upper GI bleeding and correlates with more severe hemorrhage rather than pointing to a specific diagnosis 2. Patients with leukocytosis are more likely to be tachycardic, hypotensive, require more blood transfusions, have longer hospital stays, and need surgical intervention more frequently 2. The elevated white count is a physiologic stress response to hemorrhage, not typically an indicator of infection or malignancy in this setting.

Primary Differential Diagnoses

Most Common Etiologies (in order of frequency):

Peptic Ulcer Disease (35-50% of cases)

• Duodenal ulcers are the single most common cause 1
• Gastric ulcers 1
• Risk factors: Helicobacter pylori infection, NSAID use, low-dose aspirin 1
• These account for the majority of nonvariceal UGIB cases 1

Gastroduodenal Erosions (8-15% of cases)

• Gastric erosions 1
• Duodenitis 1
• Often associated with NSAID use or stress 1

Esophageal Causes (5-15% of cases)

• Esophagitis 1
• Mallory-Weiss tears (approximately 15% of cases) 1
• Esophageal ulcers 1

Vascular Lesions

• Dieulafoy lesion (1-2% of acute bleeding, but often underrecognized) 1
  • Tortuous submucosal artery that penetrates mucosa, commonly at posterior gastric wall 1
• Angiodysplasia 1
• Vascular malformations 1

Neoplastic Causes

• Upper GI malignancy 1
• Hepatocellular carcinoma eroding into duodenum 1

Less Common but Critical Diagnoses:

Iatrogenic Causes 1

• Endoscopic ultrasound-guided biopsy complications
• ERCP-related injury
• Post-biliary stent hemorrhage
• Post-esophageal or GI stent placement
• Post-pancreatic surgery arterial injury

Rare but Life-Threatening

• Aortoenteric fistula (catastrophic hemorrhage potential) 1
• Hemobilia (1 in 500 cases of UGIB) 1
• Hemosuccus pancreaticus (1 in 500 cases of UGIB) 1

Pancreatitis-Related Bleeding 1

Stomal Marginal Ulcer (in post-surgical patients) 1

Clinical Approach Algorithm

Step 1: Assess Severity

The leukocytosis itself indicates more severe bleeding 2. Look for:

• Tachycardia (>100 bpm)
• Hypotension (systolic <100 mmHg)
• Hemodynamic instability
• These findings mandate aggressive resuscitation and early endoscopy 1

Step 2: Risk Stratification

Use validated prognostic scales for risk assessment 1. The presence of leukocytosis suggests higher-risk bleeding requiring closer monitoring 2.

Step 3: Identify Risk Factors

• NSAID or aspirin use → peptic ulcer disease 1
• Recent procedure → iatrogenic causes 1
• Known vascular disease → aortoenteric fistula 1
• Pancreatic disease → hemosuccus pancreaticus 1
• Biliary disease → hemobilia 1

Step 4: Definitive Diagnosis

Upper endoscopy (EGD) within 24 hours successfully identifies the source in 95% of cases and is the diagnostic gold standard 1. Emergency endoscopy is indicated for persistent hemorrhage with vital sign abnormalities or repeated transfusion requirements 1.

Critical Pitfalls to Avoid

Do not assume infection as the cause of leukocytosis in UGIB—it reflects hemorrhage severity, not sepsis, unless other clinical features suggest infection 2, 3.

Do not overlook Dieulafoy lesions—they are underrecognized despite causing 1-2% of acute bleeding and can be life-threatening 1.

Consider aortoenteric fistula in patients with prior aortic surgery or vascular grafts—this is a surgical emergency with catastrophic bleeding potential 1.

Remember that 75% of UGIB cases cease spontaneously, but the high-risk features (including leukocytosis) indicate this patient requires aggressive management and hospitalization 1, 2.